Amin Naseem 4
4 · Bellerophon Therapeutics, Inc. · Filed Oct 3, 2017
Insider Transaction Report
Form 4
Amin Naseem
Director
Transactions
- Purchase
Common Stock
2017-09-29+456,432→ 1,230,314 total - Purchase
Common Stock Warrants (right to buy)
2017-09-29+456,432→ 456,432 totalExercise: $1.24From: 2018-03-29Exp: 2022-09-29→ Common Stock (456,432 underlying)
Footnotes (1)
- [F1]The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.